VACCINATION WITH MMR MAY REDUCE DISEASE SEVERITY IN COVID-19 PATIENTS

  • Johannes J. Rasker University of Twente, Faculty of Behavioral Management & Social Sciences, Psychology, Health & Technology, University of Twente, Enschede, the Netherlands https://orcid.org/0000-0003-0399-2669
  • Suzanne P. Linn-Rasker Department of Rheumatology, Meander Medical Center Amersfoort, The Netherlands
Keywords: COVID-19, MMR vaccination, Child, Coronavirus

Abstract

We hypothesise that MMR vaccination is possibly a safe, cheap, effective and readily available method to reduce the severity of COVID-19 disease course in health care workers, elderly patients and other people at risk. The evidence is based on relevant literature.  Suggestions for further studies are given.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

Zhang L, Liu Y, Potential interventions for novel corona virus in China: A systematic review. Med Virol 2020; 92:479–490.

Salman S, Salem ML. Routine childhood immunization may protect against COVID-19. Med Hypotheses 2020; 140:109689.

Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J Adv Res 2020;24:91–98.

Mühlebach MD. Vaccine platform recombinant measles virus. Virus Genes 2017;53:733–740.

WHO. Measles Fact sheet. uploaded 5 December 2019

Hussain A, Ali S, Ahmed M, Hussain S. The anti-vaccination movement: a regression in modern medicine. Cureus 2018 10(7): e2919. DOI 10.7759/cureus.2919

Escriou N. Callendret B. Lorin V, Combredet C, Marianneau P, Février M., et al. Protection. from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein. Virology 2014;452–453:32–41.

Bodmer BS, Fiedler AH, Hanauer JRH, Prufer S, Muhlebach MD. Live‐attenuated bivalent measles virus‐derived vaccines targeting Middle East respiratory syndrome coronavirus induce robust and multifunctional T cell responses against both viruses in an appropriate mouse model. Virology. 2018; 521:99–107.

Malczyk AH, Kupke A, Prüfer S, Scheuplein VA, Hutzler S, Kreuz D, et al. A highly immunogenic and protective middle east respiratory syndrome coronavirus vaccine based on a recombinant measles virus vaccine platform. J Virol. 2015;89:11654–11667.

Frantz PN, Teeravechyan S, Tangy F. Measles‐derived vaccines to prevent emerging viral diseases. Microbes Infect. 2018; 20:493–500.

Gasparyan AY, Misra DP, Yessirkepov M, Zimba O. Perspectives of immune therapy in Coronavirus Disease 2019. J Korean Med Sci 2020;35(18):e176.

Published
2021-01-25